Mirae Asset Global Etfs Holdings Ltd. Care Dx, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Care Dx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 123,082 shares of CDNA stock, worth $2.87 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,082Holding current value
$2.87 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
169Shares Held
48.7MCall Options Held
60.8KPut Options Held
34.9K-
Black Rock Inc. New York, NY5.29MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$102 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.91MShares$91.3 Million1.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$69.8 Million0.89% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.14MShares$50 Million0.02% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.25B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...